The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. MBX Biosciences Inc shares valued at $45,312 were purchased by Pescovitz Ora H. on Apr 08 ’25. At $5.89 per share, Pescovitz Ora H. acquired 7,693 shares. The insider’s holdings grew to 24,329 shares worth approximately $0.24 million following the completion of this transaction.
Also, GORDON CARL L purchased 143,170 shares, netting a total of over 1,551,963 in proceeds. Following the buying of shares at $10.84 each, the insider now holds 3,255,000 shares.
Before that, GORDON CARL L had added 47,502 shares to its account. In a trade valued at $468,793, the Director bought MBX Biosciences Inc shares for $9.87 each. Upon closing the transaction, the insider’s holdings increased to 47,502 shares, worth approximately $31.87 million.
Analysts at Mizuho started covering the stock with ‘”an Outperform”‘ outlook in a report released in early August. As of July 16, 2025, Oppenheimer has initiated its “an Outperform” rating for MBX. Earlier on April 10, 2025, Citizens JMP initiated its rating. Their recommendation was “a Mkt outperform” for MBX stock.
Analyzing MBX Stock Performance
On last trading session, MBX Biosciences Inc [NASDAQ: MBX] rose 2.00% to $9.94. The stock’s lowest price that day was $9.64, but it reached a high of $10.74 in the same session. During the last five days, there has been a drop of approximately -3.12%. Over the course of the year, MBX Biosciences Inc shares have dropped approximately -57.97%.
Is MBX Biosciences Inc subject to short interest?
Stocks of MBX Biosciences Inc saw a sharp steep in short interest on 2025-08-29 dropping by -1.5 million shares to 3.84 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 5.34 million shares. A decline of -39.0% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.76 of the overall float, the days-to-cover ratio (short ratio) decline to 9.76.
Which companies own the most shares of MBX Biosciences Inc (MBX)?
In terms of MBX Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 38 in the next 12 months, up nearly 290.14% from the previous closing price of $9.74. Analysts anticipate MBX Biosciences Inc stock to reach 38 by 2025, with the lowest price target being 38. On October 08, 2024, Stifel assigned a price target of “a Buy” to the stock and initiated coverage with a $40.
